Ocugen (OCGN) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026)
Ocugen (OCGN) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | -13.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.50% |
| Dec 31, 2025 | -13.06% |
| Sep 30, 2025 | -12.75% |
| Jun 30, 2025 | -11.61% |
| Mar 31, 2025 | -9.43% |
| Dec 31, 2024 | -4.26% |
| Sep 30, 2024 | 18.39% |
| Jun 30, 2024 | 49.10% |
| Mar 31, 2024 | 122.01% |
| Dec 31, 2023 | 185.64% |
| Sep 30, 2023 | 220.32% |
| Jun 30, 2023 | 271.71% |
| Mar 31, 2023 | 313.95% |
| Dec 31, 2022 | 420.02% |
| Sep 30, 2022 | 329.37% |
| Jun 30, 2022 | 234.00% |
| Mar 31, 2022 | 152.10% |
| Dec 31, 2021 | 83.89% |
| Sep 30, 2021 | 391.36% |
| Jun 30, 2021 | 306.28% |